ALHC - Analyst Cautiously Optimistic On Alignment Healthcare Assesses Journey to Profitability Of Medicare Advantage Firm | Benzinga
Stephens initiated coverage on Alignment Healthcare Inc (NASDAQ: ALHC), saying it offers growth-oriented small-cap investors pure-play exposure to Medicare Advantage (MA), a catalyst for sustained growth in Managed Care.
The analysts Scott Fidel and Raj Kumar have initiated with an Equal Weight rating and a price target of $9.
The analysts aim to identify more concrete signs of Alignment Healthcare's business model's capacity to achieve sustainable Adjusted EBITDA profitability in 2024 and beyond.
Alignment Healthcare has developed several significant capabilities, showcasing robust MA ...